Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine for subjective cognitive impairment without dementia
2010-020737-50Phase 2Completed
- Sponsor
- Merz
- Start
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Memory complaint (SMC) comparing Memantine 10 mg/day with Placebo (2 arms). Primary endpoint: Patient Global Impression of Change. Started Aug 2010; status: completed.
02
Drugs
memantine
03
Conditions
Memory complaint (SMC)
Beyond the preview
Go deeper on 2010-020737-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020737-50.